Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2018
Price : $35 *
At a glance
- Drugs Pegvisomant (Primary) ; Somatostatins
- Indications Acromegaly
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Dec 2016 Planned End Date changed from 1 Aug 2015 to 1 Aug 2017.
- 07 Dec 2016 Planned primary completion date changed from 1 May 2015 to 1 May 2017.